Insmed | INSM - Aktuelle Verpflichtungen





Aktuelle Verpflichtungen Veränderung Datum
BioMarin Pharmaceutical USD 1.6B 59.17M 2026-09
Cytokinetics USD 353.42M 171.99M 2026-09
DBV Technologies USD 58.5M 4.2M 2026-09
Gilead Sciences USD 12B 982M 2026-09
Heron Therapeutics USD 92.14M 1.63M 2026-06
Insmed USD 596.57M 157.83M 2026-09
Novartis USD 32.52B 1.15B 2026-09
Regeneron Pharmaceuticals USD 6.2B 671.5M 2026-09
Sarepta Therapeutics USD 656.35M 153.44M 2026-09
Ultragenyx Pharmaceutical USD 389M 38M 2026-09
Vertex Pharmaceuticals USD 5B 1.06B 2026-09